The median prescribed doses varied (depending on nature of the tumor): pituitary tumor (14.4±2.1Gy), meningioma (22.5±2.7Gy), AVM (20.4±1.8Gy), acoustic neuroma (14.1±1.9Gy), brain metastases (20.2±2.4Gy), craniopharyngeal tumor (12.8±1.4Gy), pineal tumor (16.3±1.8Gy), cavernoma (24.2±2.1Gy), astocytoma (16.6±2.5Gy), medulloblastoma (16.1±2Gy), ependymoma (17.3±2.6Gy), lymphoma (15.3±2.7Gy), others (15.1±2.6Gy).